The EMA Management Board adopted the EMA Annual Report 2025. This year marked another strong year for the regulation of medicines in the European Union. EMA supplied 104 medicines. The report summarizes the agency's key activities and results for the year 2025. The Board meeting was held in March 2026. The document highlights the successful course of drug regulation in the EU.